Your browser doesn't support javascript.
loading
A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country.
Tricou, Vianney; Eyre, Susannah; Ramjee, Mahadev; Collini, Paul; Mojares, Zenaida; Loeliger, Edde; Mandaric, Sanja; Rauscher, Martina; Brose, Manja; Lefevre, Inge; Folschweiller, Nicolas; Wallace, Derek.
Afiliação
  • Tricou V; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland. Electronic address: vianney.tricou@takeda.com.
  • Eyre S; Medical Operations, Synexus Merseyside Clinical Research Centre, Liverpool, L22 0LG Merseyside, UK.
  • Ramjee M; Synexus Lancashire Clinical Research Centre, Chorley, PR7 7NA Lancashire, UK.
  • Collini P; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, S10 2RX Sheffield, UK.
  • Mojares Z; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland.
  • Loeliger E; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland.
  • Mandaric S; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland.
  • Rauscher M; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland.
  • Brose M; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland.
  • Lefevre I; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland.
  • Folschweiller N; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland.
  • Wallace D; Global Dengue Program, Takeda Vaccines, Inc., Boston, 02139 MA, USA.
Vaccine ; 41(7): 1398-1407, 2023 02 10.
Article em En | MEDLINE | ID: mdl-36681529
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Vírus da Hepatite A / Dengue / Vírus da Dengue / Vacinas contra Dengue / Hepatite A Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Vírus da Hepatite A / Dengue / Vírus da Dengue / Vacinas contra Dengue / Hepatite A Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article País de publicação: Holanda